Search results
Results from the WOW.Com Content Network
A Gamma Knife typically contains 201 cobalt-60 sources of approximately 30 curies each (1.1 TBq), placed in a hemispheric array in a heavily shielded assembly. The device aims gamma radiation through a target point in the patient's brain. The patient wears a specialized helmet that is surgically fixed to the skull, so that the brain tumor ...
The Gamma Knife relied on a stereotactic frame screwed into the patient's skull as an external surrogate to triangulate the location of the subject's tumor; Adler instead wanted to rely on recent medical imaging advancements and internal anatomical structures to guide the beam. Dr. Adler also sought to eliminate the costs to secure and ...
To assure quality of patient care the procedure involves a multidisciplinary team consisting of a radiation oncologist, medical physicist, and radiation therapist. [9] [10] Dedicated, commercially available stereotactic radiosurgery programs are provided by the irrespective Gamma Knife, [11] CyberKnife, [12] and Novalis Radiosurgery [13 ...
Gamma-knife radiation is the favored mechanism of radiosurgery. It provides a precise radiation dose to the cerebral cavernous hemangioma while relatively sparing the surrounding tissue. [27] These treatment approaches for cavernous hemangiomas in other regions of the body have limited research.
Radiation therapy or radiotherapy (RT, RTx, or XRT) is a treatment using ionizing radiation, generally provided as part of cancer therapy to either kill or control the growth of malignant cells.
The development of the system began in 1989 with contributions from John R. Adler, a surgeon at Stanford University, and Peter and Russell Schonberg of Schonberg Radiation Corporation. [3] This work expanded upon earlier efforts in the 1980s to adapt standard linear accelerators for radiosurgery .
Generally, single-session Gamma Knife radiosurgery is limited in use to VSs less than 3 cm in diameter to avoid possible complications with facial nerves, brainstem and the cochlea apparatus. [26] The risk of radiation-induced secondary tumors is very small, in the range of 0.01-0.02%. The risk for NF2 patients appears to be slightly higher.
This compelled Leksell to consider other radiation sources and he started designing the cobalt-60 gamma unit, which was fully integrated with the stereotactic system. The development of the ‘‘beam-knife’’ took place after Leksell had been appointed successor to Olivecrona in 1960 and the first unit was inaugurated in 1967.